PVLA vs TDG · $1.64B cap vs P/E 41, rev $8.83B
Palvella Therapeutics, Inc (PVLA) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Palvella Therapeutics, Inc (PVLA) is a biotechnology company listed on NASDAQ.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
PVLA does not have a complete income-statement cache yet.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
PVLA currently screens at market cap $1.64B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the PVLA and TDG stock pages for the full models.
Not investment advice.